1.
Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA. Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells. Haematologica [Internet]. 2016Feb.1 [cited 2026Nov.16];101(2):e59-e62. Available from: https://haematologica.org/article/view/7639